Speaking to the Business Post, Sharon Cunningham, Shorla’s CEO, said the funding would be used to “accelerate the growth of its oncology portfolio by advancing its pipeline, bringing therapies to market that will address drug shortages, and improving the preparation and application of oncology medication.”
Read more at https://www.businesspost.ie/article/shorla-oncology-raises-35m-to-accelerate-growth/
